Scott Henry
Stock Analyst at Alliance Global Partners
(1.70)
# 3,236
Out of 4,896 analysts
52
Total ratings
39.62%
Success rate
-2.46%
Average return
Main Sectors:
Stocks Rated by Scott Henry
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNON Tenon Medical | Initiates: Buy | $3 | $1.02 | +194.12% | 1 | Apr 9, 2025 | |
| QSI Quantum-Si incorporated | Initiates: Buy | $3.75 | $1.73 | +116.76% | 1 | Feb 7, 2025 | |
| VVOS Vivos Therapeutics | Maintains: Buy | $8.25 → $6 | $6.82 | -12.02% | 4 | Nov 19, 2024 | |
| LPCN Lipocine | Initiates: Buy | $10 | $3.25 | +207.69% | 1 | Sep 24, 2024 | |
| ASRT Assertio Holdings | Initiates: Buy | $2.75 | $0.69 | +297.97% | 1 | May 28, 2024 | |
| DERM Journey Medical | Initiates: Buy | $8.5 | $7.18 | +18.38% | 2 | Feb 16, 2024 | |
| RNXT RenovoRx | Initiates: Buy | $4 | $1.29 | +211.28% | 3 | Feb 2, 2024 | |
| FBIO Fortress Biotech | Maintains: Buy | $30 → $15 | $1.89 | +693.65% | 2 | Nov 29, 2023 | |
| RVPH Reviva Pharmaceuticals Holdings | Reiterates: Buy | $12 | $0.39 | +2,967.48% | 2 | Oct 30, 2023 | |
| CSBR Champions Oncology | Maintains: Buy | $9 → $7.5 | $8.10 | -7.41% | 2 | Sep 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $13 | $11.34 | +14.64% | 4 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $24 | $31.11 | -22.85% | 2 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $10 → $16 | $21.81 | -28.93% | 2 | Aug 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $55 → $58 | $83.65 | -30.66% | 6 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $36 | $57.98 | -37.91% | 1 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $11 | $1.01 | +989.11% | 3 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $6 | $4.16 | +44.23% | 2 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6,000 → $5,750 | $2.75 | +208,990.91% | 1 | Feb 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.40 | - | 1 | Dec 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $7 | $2.08 | +236.54% | 3 | Nov 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $40.87 | - | 5 | Apr 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.69 | - | 2 | Mar 26, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.37 | - | 1 | Nov 10, 2017 |
Tenon Medical
Apr 9, 2025
Initiates: Buy
Price Target: $3
Current: $1.02
Upside: +194.12%
Quantum-Si incorporated
Feb 7, 2025
Initiates: Buy
Price Target: $3.75
Current: $1.73
Upside: +116.76%
Vivos Therapeutics
Nov 19, 2024
Maintains: Buy
Price Target: $8.25 → $6
Current: $6.82
Upside: -12.02%
Lipocine
Sep 24, 2024
Initiates: Buy
Price Target: $10
Current: $3.25
Upside: +207.69%
Assertio Holdings
May 28, 2024
Initiates: Buy
Price Target: $2.75
Current: $0.69
Upside: +297.97%
Journey Medical
Feb 16, 2024
Initiates: Buy
Price Target: $8.5
Current: $7.18
Upside: +18.38%
RenovoRx
Feb 2, 2024
Initiates: Buy
Price Target: $4
Current: $1.29
Upside: +211.28%
Fortress Biotech
Nov 29, 2023
Maintains: Buy
Price Target: $30 → $15
Current: $1.89
Upside: +693.65%
Reviva Pharmaceuticals Holdings
Oct 30, 2023
Reiterates: Buy
Price Target: $12
Current: $0.39
Upside: +2,967.48%
Champions Oncology
Sep 22, 2023
Maintains: Buy
Price Target: $9 → $7.5
Current: $8.10
Upside: -7.41%
Aug 16, 2023
Maintains: Buy
Price Target: $10 → $13
Current: $11.34
Upside: +14.64%
May 3, 2023
Maintains: Buy
Price Target: $19 → $24
Current: $31.11
Upside: -22.85%
Aug 24, 2022
Downgrades: Neutral
Price Target: $10 → $16
Current: $21.81
Upside: -28.93%
Aug 3, 2021
Maintains: Neutral
Price Target: $55 → $58
Current: $83.65
Upside: -30.66%
Aug 2, 2021
Maintains: Buy
Price Target: $32 → $36
Current: $57.98
Upside: -37.91%
May 12, 2021
Maintains: Buy
Price Target: $9 → $11
Current: $1.01
Upside: +989.11%
Feb 26, 2021
Maintains: Buy
Price Target: $4 → $6
Current: $4.16
Upside: +44.23%
Feb 16, 2021
Maintains: Buy
Price Target: $6,000 → $5,750
Current: $2.75
Upside: +208,990.91%
Dec 4, 2020
Downgrades: Neutral
Price Target: n/a
Current: $3.40
Upside: -
Nov 11, 2020
Upgrades: Buy
Price Target: $7
Current: $2.08
Upside: +236.54%
Apr 18, 2019
Upgrades: Buy
Price Target: n/a
Current: $40.87
Upside: -
Mar 26, 2018
Downgrades: Neutral
Price Target: n/a
Current: $0.69
Upside: -
Nov 10, 2017
Downgrades: Neutral
Price Target: n/a
Current: $4.37
Upside: -